-
公开(公告)号:EP2874611A1
公开(公告)日:2015-05-27
申请号:EP13739677.6
申请日:2013-07-18
IPC分类号: A61K9/20 , A61K31/192 , A61K31/196 , A61K31/4439
CPC分类号: A61K9/205 , A61K31/192 , A61K31/196 , A61K31/4439
摘要: A solid gastro-resistant delayed release pharmaceutical form obtained without using gastro-resistant film coating is described.
-
公开(公告)号:EP3525761A1
公开(公告)日:2019-08-21
申请号:EP17784260.6
申请日:2017-10-10
IPC分类号: A61K9/16 , A61K31/145 , A61K31/7024
-
公开(公告)号:EP3308773A1
公开(公告)日:2018-04-18
申请号:EP16193180.3
申请日:2016-10-11
IPC分类号: A61K9/16 , A61K31/145 , A61K31/7024
CPC分类号: A61K9/1617 , A61K9/0095 , A61K9/167 , A61K9/5084 , A61K31/145 , A61K31/7024 , A61K2300/00
摘要: Oral cysteamine formulation consisting of dry layered lipid matrix microparticles useful for treating cystinosis and neurodegenerative disorders are described.
摘要翻译: 描述了用于治疗胱氨酸血症和神经变性疾病的由干燥的分层脂质基质微粒组成的口服半胱胺制剂。
-
公开(公告)号:EP2874611B1
公开(公告)日:2016-09-14
申请号:EP13739677.6
申请日:2013-07-18
IPC分类号: A61K9/20 , A61K31/192 , A61K31/196 , A61K31/4439
CPC分类号: A61K9/205 , A61K31/192 , A61K31/196 , A61K31/4439
-
公开(公告)号:EP3796888A1
公开(公告)日:2021-03-31
申请号:EP19724505.3
申请日:2019-05-17
IPC分类号: A61K9/00 , A61K45/06 , A61K31/145 , A61K9/16 , A61P11/12
-
公开(公告)号:EP2874610B1
公开(公告)日:2018-08-29
申请号:EP13739675.0
申请日:2013-07-18
IPC分类号: A61K9/00 , A61K9/20 , A61K9/24 , A61K45/06 , A61K31/192 , A61K31/195 , A61K9/46
CPC分类号: A61K9/0065 , A61K9/0007 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2059 , A61K9/209 , A61K9/2095 , A61K31/192 , A61K31/195 , A61K45/06 , A61K2300/00
摘要: An oral trilayered formulation with multi-kinetic release in different sites of the gastro-intestinal tract, particularly suitable for the administration of combinations of active ingredients is described.
-
公开(公告)号:EP2874610A1
公开(公告)日:2015-05-27
申请号:EP13739675.0
申请日:2013-07-18
CPC分类号: A61K9/0065 , A61K9/0007 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2059 , A61K9/209 , A61K9/2095 , A61K31/192 , A61K31/195 , A61K45/06 , A61K2300/00
摘要: An oral trilayered formulation with multi-kinetic release in different sites of the gastro-intestinal tract, particularly suitable for the administration of combinations of active ingredients is described.
-
-
-
-
-
-